[Treatment of joint diseases with dimethyl sulfoxide (DMSO) applications]. 1979

A P Aliab'eva, and T F Akimova, and T M Trusova

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D004121 Dimethyl Sulfoxide A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation. DMSO,Dimethyl Sulphoxide,Dimethylsulfoxide,Dimethylsulphinyl,Dimethylsulphoxide,Dimexide,Rheumabene,Rimso,Rimso 100,Rimso-50,Sclerosol,Sulfinylbis(methane),Rimso 50,Rimso50,Sulfoxide, Dimethyl,Sulphoxide, Dimethyl
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012996 Solutions The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed) Solution

Related Publications

A P Aliab'eva, and T F Akimova, and T M Trusova
January 1989, Minerva medica,
A P Aliab'eva, and T F Akimova, and T M Trusova
October 1980, The Medical letter on drugs and therapeutics,
A P Aliab'eva, and T F Akimova, and T M Trusova
January 1966, Canadian journal of comparative medicine and veterinary science,
A P Aliab'eva, and T F Akimova, and T M Trusova
May 1965, The Medical letter on drugs and therapeutics,
A P Aliab'eva, and T F Akimova, and T M Trusova
September 1967, Zeitschrift fur Haut- und Geschlechtskrankheiten,
A P Aliab'eva, and T F Akimova, and T M Trusova
January 1986, The Cornell veterinarian,
A P Aliab'eva, and T F Akimova, and T M Trusova
January 1982, The Canadian journal of hospital pharmacy,
A P Aliab'eva, and T F Akimova, and T M Trusova
February 2009, Lasers in surgery and medicine,
A P Aliab'eva, and T F Akimova, and T M Trusova
April 1981, American family physician,
A P Aliab'eva, and T F Akimova, and T M Trusova
June 1965, Alaska medicine,
Copied contents to your clipboard!